Ef cacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial

HIGHLIGHTS

• who: . and collaborators from the of Chinese Medical Sciences, China Fourth Military Medical University, China have published the paper: Ef cacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial, in the Journal: (JOURNAL) of 13/07/2019
• what: In strict compliance with the trial procedures and quality_control, this study aims to provide high-quality evidence for the assessment of efficacy and safety of NTF capsules in treating of HT-CSVD with QDBS syndrome. Exclusion criteria Participants who meet the following . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.